Obstetrics/Gynecology Market Research Reports & Industry Analysis
Obstetrics/Gynecology Industry Research & Market Reports
-
2025 Pregnancy, Childbirth and The Puerperium Global Market Size & Growth Report with Updated Analysis & Forecasts
... 22 subregions, and 195 countries. Figures are from 2013 through 2024, with forecasts for 2025 and the next 5 years. The historical data utilizes in-depth survey results from companies selling pregnancy, childbirth and the puerperium ... Read More
-
Surgical Procedures Market by Surgery Type (Gynecology Surgery, Urology Surgery, Neurosurgery, Cystectomy, Sacrectomy, Orthopedic Surgery, General Surgery, Thoracic Surgery, and Others) - Global Opportunity Analysis and Industry Forecast, 2025–2030
... are more likely to develop age-related health issues such as cardiovascular diseases (CVDs), cancer, osteoarthritis, and others that may require surgical intervention. This, in turn, increases the demand for surgical procedures. With improved medical care ... Read More
-
Medical Robotics Market by Product and Services (Instrument and Accessories, Robotic Systems, Services, and Consumables), by Application (General Surgery, Orthopedic Surgery, Neurosurgery, Gynecological Surgery, Urological Surgery, Oncological Surgery, Transoral Surgery, Physical Rehabilitation, External Beam Radiation Therapy, and Other Applications), by End Users (Hospitals, Home Care Settings, Ambulatory Surgery Centers, Rehabilitation Center, and Other End-Users) - Global Opportunity Analysis and Industry Forecast, 2024– 2030
... medical robots, particularly exoskeleton devices, plays a crucial role in addressing the challenges posed by conditions such as spinal cord injury, rehabilitation, multiple sclerosis, and stroke. The surge in cases of these health issues has ... Read More
-
Hormone Replacement Therapy Market Report by Product (Estrogen Replacement Therapy, Human Growth Hormone Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Therapy, and Others), Route of Administration (Oral, Parenteral, Transdermal), Type of Disease (Menopause, Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, and Others), and Region 2025-2033
... 2025-2033. The rising prevalence of hormonal disorders, increased awareness and acceptance of HRT, expanding geriatric population, significant technological advancements and ongoing innovations in delivery methods, supportive government initiatives and reimbursement policies are some of the ... Read More
-
Pain Management Drugs Market Report by Drug Class (NSAIDs, Anesthetics, Anticonvulsants, Antimigraine Agents, Antidepressants, Opioids, and Others), Indication (Musculoskeletal Pain, Surgical and Trauma Pain, Cancer Pain, Neuropathic Pain, Migraine Pain, Obstetrical Pain, Fibromyalgia Pain, Burn Pain, Dental/Facial Pain, Pediatric Pain, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2025-2033
... 2025-2033. The market is experiencing robust growth driven by the increasing prevalence of chronic diseases, rapid advancements in pain management therapies, heightened awareness and education about pain management, the implementation of supportive government and regulatory ... Read More
-
Intrauterine Devices (IUD) Market Report by Product (Hormonal Intrauterine Device, Copper Intrauterine Device), End-Use (Hospitals, Gynaecology Clinics, Community Healthcare, and Others), and Region 2025-2033
... The market is propelled by the rising awareness about long-acting reversible contraception (LARC), significant technological advancements in IUD design and insertion techniques, favorable government initiatives promoting family planning and contraception access. Intrauterine Devices (IUDs) are ... Read More
-
Intravaginal Insemination
... CAGR of 7.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$130.1 Million While China is Forecast to Grow at 10.8% CAGR The Intravaginal Insemination market in the U.S. is estimated at ... Read More
-
Microwave Ablation
... CAGR of 13.2% over the analysis period 2024-2030. Liver Cancer Application, one of the segments analyzed in the report, is expected to record a 15.2% CAGR and reach US$215.5 Million by the end of the ... Read More
-
Intrauterine Insemination
... CAGR of 8.1% over the analysis period 2024-2030. The U.S. Market is Estimated at US$464.8 Million While China is Forecast to Grow at 11.7% CAGR The Intrauterine Insemination market in the U.S. is estimated at ... Read More
-
Energy-based Therapeutics
... CAGR of 3.6% over the analysis period 2024-2030. Laser-based Technology, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$3.6 Billion by the end of the analysis ... Read More
-
Cervical Cancer Endoscopic Devices
... 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Optical Colposcopes, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$668.1 Million by the ... Read More
-
Vaginitis Therapeutics
... CAGR of 7.6% over the analysis period 2024-2030. Anti-Bacterial Product, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$2.7 Billion by the end of the analysis ... Read More
-
Amniocentesis Needles
... CAGR of 2.1% over the analysis period 2024-2030. 150 mm & Above Needles, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$67.3 Million by the end ... Read More
-
Endometrial Cancer Treatment
... at a CAGR of 5.0% over the analysis period 2024-2030. Chemotherapy, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$31.3 Billion by the end of the ... Read More
-
Gynecological Cancer Drugs
... at a CAGR of 5.1% over the analysis period 2024-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$12.1 Billion by the end of ... Read More
-
Cervical Cancer Treatment
... at a CAGR of 6.0% over the analysis period 2024-2030. Squamous Cell Carcinoma (SCC) Treatment, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$9.1 Billion by ... Read More
-
Polycystic Ovary Syndrome (PCOS) Treatment
... Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Insulin-Sensitizing Agents, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.3 Billion ... Read More
-
Uterine Cancer Therapeutics and Diagnostics
... Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Endometrial Carcinomas Therapeutics & Diagnostics, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and ... Read More
-
Global Ovarian Cancer Drugs Market - 2024-2032
... during the forecast period 2024-2031. Ovarian cancer is the growth of abnormal cancerous cells in the ovaries, fallopian tube, or peritoneum- the major parts of the woman’s reproductive system. Ovaries are made up of different ... Read More
-
Global Hormone Replacement Therapy Market - 2024 - 2032
... of 6.1% during the forecast period 2024-2032. Hormone Replacement Therapy (HRT) is a treatment that involves the use of hormones to address symptoms linked to hormonal imbalances, particularly during menopause, as well as in conditions ... Read More
-
Assisted Reproductive Technology Global Market Report 2025
... End-User: Hospitals; Fertility ClinicsCovering: Cooper Surgical Inc.; Ferring Pharmaceuticals Ltd.; Hamilton Thorne Ltd.; Merck KGaA; Genea Limited Assisted Reproductive Technology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management ... Read More
-
Biosimilar Market Report by Molecule (Infliximab, Insulin Glargine, Epoetin Alfa, Etanercept, Filgrastim, Somatropin, Rituximab, Follitropin Alfa, Adalimumab, Pegfilgrastim, Trastuzumab, Bevacizumab, and Others), Indication (Auto-Immune Diseases, Blood Disorders, Diabetes, Oncology, Growth Deficiency, Female Infertility, and Others), Manufacturing Type (In-house Manufacturing, Contract Manufacturing), and Region 2025-2033
... Manufacturing Type (In-house Manufacturing, Contract Manufacturing), and Region 2025-2033 The global biosimilar market size reached USD 26.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 185.1 Billion by 2033, exhibiting ... Read More
-
2025 Global Forecast for Cervical Cancer Molecular Diagnostics Market (2026-2031 Outlook)-High Tech Outlook Report
... The product or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD ... Read More
-
2025 Global: Estrogen Replacement Therapy Market - Innovative Markets Forecast (2031) report
... industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only market ... Read More
-
2025 Global: Amniotic Membrane Market - Innovative Markets Forecast (2031) report
... forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only market research ... Read More
Research Assistance
